8HKN
Mutated human ADP-ribosyltransferase 2 (PARP2) catalytic domain bound to approved drug Fluzoparib
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SSRF BEAMLINE BL02U1 |
Synchrotron site | SSRF |
Beamline | BL02U1 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2021-12-14 |
Detector | DECTRIS EIGER X 16M |
Wavelength(s) | 0.97918 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 41.010, 85.584, 95.413 |
Unit cell angles | 90.00, 90.03, 90.00 |
Refinement procedure
Resolution | 36.980 - 2.500 |
R-factor | 0.1852 |
Rwork | 0.181 |
R-free | 0.26120 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | Alphafold model |
RMSD bond length | 0.009 |
RMSD bond angle | 1.588 |
Data scaling software | Aimless |
Phasing software | MOLREP |
Refinement software | PHENIX (1.20.1_4487) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 39.980 | 2.589 |
High resolution limit [Å] | 2.500 | 2.500 |
Number of reflections | 22769 | 2278 |
<I/σ(I)> | 24.39 | |
Completeness [%] | 99.2 | |
Redundancy | 4.8 | |
CC(1/2) | 0.999 | 0.965 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 291 | 25% PEG-3350, 0.1 M Tris-HCl pH 8.5 |